Affirm's Funding Vulnerabilities Exposed as Private Credit Stress Hits Consumer Loans

What happened

A Wall Street Journal report reveals that a fund holding consumer and small-business loans from Affirm and others is facing stress, signaling a spreading investor exodus in the private-credit market. Affirm's business model depends critically on access to stable, low-cost funding through securitizations and institutional facilities to fuel its growth. The DeepValue master report already flags this as a key risk, with Affirm's balance sheet showing high leverage (Net Debt/EBITDA ~9x) and thin interest coverage (~0.3x), leaving it exposed to funding shocks. Despite achieving GAAP profitability and strong free cash flow, the stock trades at a lofty ~104x P/E, a 204% premium to intrinsic value, embedding optimistic assumptions. This news directly challenges those assumptions by highlighting how credit market turmoil could constrain Affirm's funding, pressure its economics, and trigger downside in its overvalued shares.

Implication

The stress in private-credit funds could lead to tighter or more expensive funding for Affirm, squeezing margins and potentially slowing its GMV growth. With sector delinquencies already near 30%, any credit deterioration could spike loan losses, undermining the narrative of superior underwriting. Affirm's thin equity cushion and high leverage mean it has limited flexibility to absorb shocks, raising the risk of dilutive capital raises or asset sales. Regulatory uncertainty around BNPL could worsen in a stressed environment, as authorities may accelerate stricter rules that compress profitability. Given the stock's premium valuation, even modest setbacks in funding or credit could catalyze significant price declines, making the risk/reward increasingly unfavorable for holders.

Thesis delta

The DeepValue report's POTENTIAL SELL stance was based on overvaluation and latent funding risks, but this news shows those risks are materializing in the market. This shifts the thesis from a cautionary view to a more urgent sell, as the funding vulnerability is no longer hypothetical but actively pressuring Affirm's ecosystem. Investors should now assign higher probability to downside scenarios, strengthening the case to reduce or avoid exposure.